145 related articles for article (PubMed ID: 36056785)
1. Anti-proliferation effects of Apatinib in combination with Curcumin in breast cancer cells.
Farhoudi Sefidan Jadid M; Jahangirzadehd G; Behroozi J
Horm Mol Biol Clin Investig; 2023 Mar; 44(1):27-32. PubMed ID: 36056785
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma.
Firouzi Amoodizaj F; Baghaeifar S; Taheri E; Farhoudi Sefidan Jadid M; Safi M; Seyyed Sani N; Hajazimian S; Isazadeh A; Shanehbandi D
J Biochem Mol Toxicol; 2020 Jun; 34(6):e22486. PubMed ID: 32128952
[TBL] [Abstract][Full Text] [Related]
3. Apatinib increases anticancer potential of doxorubicin in breast cancer cells.
Aghaei E; Soltanzadeh H; Kohan L; Heiat M
Mol Biol Rep; 2023 Dec; 50(12):10137-10145. PubMed ID: 37921980
[TBL] [Abstract][Full Text] [Related]
4. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
5. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line.
Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E
Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965
[TBL] [Abstract][Full Text] [Related]
7. Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation.
Mohammed F; Rashid-Doubell F; Taha S; Cassidy S; Fredericks S
Int J Oncol; 2020 Aug; 57(2):445-455. PubMed ID: 32626932
[TBL] [Abstract][Full Text] [Related]
8. Combination of arabinogalactan and curcumin induces apoptosis in breast cancer cells in vitro and inhibits tumor growth via overexpression of p53 level in vivo.
Moghtaderi H; Sepehri H; Attari F
Biomed Pharmacother; 2017 Apr; 88():582-594. PubMed ID: 28152473
[TBL] [Abstract][Full Text] [Related]
9. Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells.
Karami P; Othman G; Housein Z; Salihi A; Hosseinpour Feizi MA; Azeez HJ; Babaei E
Molecules; 2022 May; 27(9):. PubMed ID: 35566271
[TBL] [Abstract][Full Text] [Related]
10. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
11. Quinacrine and curcumin synergistically increased the breast cancer stem cells death by inhibiting ABCG2 and modulating DNA damage repair pathway.
Nayak D; Tripathi N; Kathuria D; Siddharth S; Nayak A; Bharatam PV; Kundu C
Int J Biochem Cell Biol; 2020 Feb; 119():105682. PubMed ID: 31877386
[TBL] [Abstract][Full Text] [Related]
12. Cellular uptake and apoptotic properties of gemini curcumin in gastric cancer cells.
Emami A; Babaei E; Nagishbandi A; Azeez HJ; Feizi MAH; Golizadeh A
Mol Biol Rep; 2021 Nov; 48(11):7215-7222. PubMed ID: 34623595
[TBL] [Abstract][Full Text] [Related]
13. Active Compounds from
Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative and apoptotic effect of gemini curcumin in p53-wild type and p53-mutant colorectal cancer cell lines.
Ebrahimi M; Babaei E; Neri F; Feizi MAH
Int J Pharm; 2021 May; 601():120592. PubMed ID: 33857585
[TBL] [Abstract][Full Text] [Related]
15. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
16. Curcumin and Thymoquinone Combination Attenuates Breast Cancer Cell Lines' Progression.
El-Far AH; Saddiq AA; Mohamed SA; Almaghrabi OA; Mousa SA
Integr Cancer Ther; 2022; 21():15347354221099537. PubMed ID: 35583244
[TBL] [Abstract][Full Text] [Related]
17. Efficient synergistic combination effect of Quercetin with Curcumin on breast cancer cell apoptosis through their loading into Apo ferritin cavity.
Mansourizadeh F; Alberti D; Bitonto V; Tripepi M; Sepehri H; Khoee S; Geninatti Crich S
Colloids Surf B Biointerfaces; 2020 Jul; 191():110982. PubMed ID: 32220813
[TBL] [Abstract][Full Text] [Related]
18. Tocotrienol Nanoemulsion Platform of Curcumin Elicit Elevated Apoptosis and Augmentation of Anticancer Efficacy against Breast and Ovarian Carcinomas.
Steuber N; Vo K; Wadhwa R; Birch J; Iacoban P; Chavez P; Elbayoumi TA
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792193
[TBL] [Abstract][Full Text] [Related]
19. Development of Curcumin-Loaded Solid Lipid Nanoparticles Utilizing Glyceryl Monostearate as Single Lipid Using QbD Approach: Characterization and Evaluation of Anticancer Activity Against Human Breast Cancer Cell Line.
Bhatt H; Rompicharla SVK; Komanduri N; Aashma S; Paradkar S; Ghosh B; Biswas S
Curr Drug Deliv; 2018; 15(9):1271-1283. PubMed ID: 29732970
[TBL] [Abstract][Full Text] [Related]
20. Enhanced anticancer potency of hydroxytyrosol and curcumin by PLGA-PAA nano-encapsulation on PANC-1 pancreatic cancer cell line.
Jadid MFS; Shademan B; Chavoshi R; Seyyedsani N; Aghaei E; Taheri E; Goleij P; Hajazimian S; Karamad V; Behroozi J; Sabet MN; Isazadeh A; Baradaran B
Environ Toxicol; 2021 Jun; 36(6):1043-1051. PubMed ID: 33496383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]